Loading...
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Angiogenesis has been implicated in ovarian cancer pathogenesis. Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody, has recently been incorporated in ovarian cancer treatment in combination with chemotherapy both in a frontline setting and in disease recurrence. However, re...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4199819/ https://ncbi.nlm.nih.gov/pubmed/25336975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S65522 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|